Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients.

Berrin Benli Yavuz Fahriye Kılınç Gul Kanyilmaz Meryem Aktan

Published in: Journal of neuro-oncology (2023)

PKM2 is an independent prognostic factor for survival and is associated with poor prognosis in GBM patients treated with radiotherapy. It may be a potential therapeutic target for anticancer therapy.

Keyphrases

poor prognosis
prognostic factors
long non coding rna
end stage renal disease
ejection fraction
chronic kidney disease
early stage
peritoneal dialysis
radiation therapy
locally advanced
radiation induced
stem cells
tyrosine kinase
patient reported outcomes
rectal cancer
replacement therapy